Follow
Eric Ransom
Eric Ransom
Verified email at UHhospitals.org
Title
Cited by
Cited by
Year
Use of mCherry red fluorescent protein for studies of protein localization and gene expression in Clostridium difficile
EM Ransom, CD Ellermeier, DS Weiss
Applied and environmental microbiology 81 (5), 1652-1660, 2015
1242015
Identification and characterization of a gene cluster required for proper rod shape, cell division, and pathogenesis in Clostridium difficile
EM Ransom, KB Williams, DS Weiss, CD Ellermeier
Journal of bacteriology 196 (12), 2290-2300, 2014
552014
Evaluation of optimal blood culture incubation time to maximize clinically relevant results from a contemporary blood culture instrument and media system
EM Ransom, Z Alipour, MA Wallace, CAD Burnham
Journal of clinical microbiology 59 (3), 10.1128/jcm. 02459-20, 2021
382021
Multiple factors contribute to bimodal toxin gene expression in Clostridioides (Clostridium) difficile
EM Ransom, GM Kaus, PM Tran, CD Ellermeier, DS Weiss
Molecular microbiology 110 (4), 533-549, 2018
382018
Rationale for a Neisseria gonorrhoeae Susceptible–only Interpretive Breakpoint for Azithromycin
EN Kersh, V Allen, E Ransom, M Schmerer, S Cyr, K Workowski, ...
Clinical Infectious Diseases 70 (5), 798-804, 2020
342020
Interspecies Signaling between Veillonella atypica and Streptococcus gordonii Requires the Transcription Factor CcpA
BP Johnson, BJ Jensen, EM Ransom, KA Heinemann, KM Vannatta, ...
Journal of bacteriology 191 (17), 5563-5565, 2009
322009
Genomic prediction of antimicrobial resistance: ready or not, here it comes!
EM Ransom, RF Potter, G Dantas, CAD Burnham
Clinical chemistry 66 (10), 1278-1289, 2020
282020
Staphylococcus aureus injection drug use-associated bloodstream infections are propagated by community outbreaks of diverse lineages
LR Marks, JJ Calix, JA Wildenthal, MA Wallace, SS Sawhney, ...
Communications Medicine 1 (1), 52, 2021
252021
Use of mCherryOpt Fluorescent Protein in Clostridium difficile
EM Ransom, DS Weiss, CD Ellermeier
Clostridium difficile: methods and protocols, 53-67, 2016
252016
In vitro activity of novel antifungal olorofim against filamentous fungi and comparison to eight other antifungal agents
O Georgacopoulos, NS Nunnally, EM Ransom, D Law, M Birch, ...
Journal of Fungi 7 (5), 378, 2021
242021
Comparison of extraction methods and thermocyclers for SARS-CoV-2 molecular detection using clinical specimens
EM Ransom, RF Potter, MA Wallace, KF Mitchell, ML Yarbrough, ...
Journal of clinical microbiology 58 (10), 10.1128/jcm. 01622-20, 2020
212020
Validation of aztreonam-avibactam susceptibility testing using digitally dispensed custom panels
E Ransom, A Bhatnagar, JB Patel, MJ Machado, S Boyd, N Reese, ...
Journal of Clinical Microbiology 58 (4), 10.1128/jcm. 01944-19, 2020
192020
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales
A Bhatnagar, EM Ransom, MJ Machado, S Boyd, N Reese, K Anderson, ...
Journal of Antimicrobial Chemotherapy 76 (4), 979-983, 2021
142021
IL-7 immunotherapy in a nonimmunocompromised patient with intractable fungal wound sepsis
IR Turnbull, MB Mazer, MH Hoofnagle, JP Kirby, JM Leonard, ...
Open forum infectious diseases 8 (6), ofab256, 2021
122021
Deep convolutional neural networks implementation for the analysis of urine culture
DJ Alouani, EM Ransom, M Jani, CA Burnham, DD Rhoads, N Sadri
Clinical chemistry 68 (4), 574-583, 2022
102022
Comparative genomics of borderline oxacillin-resistant Staphylococcus aureus detected during a Pseudo-outbreak of methicillin-resistant S. aureus in a neonatal intensive care unit
SS Sawhney, EM Ransom, MA Wallace, PJ Reich, G Dantas, ...
MBio 13 (1), e03196-21, 2022
72022
Fecal microbiota transplantations: where are we, where are we going, and what is the role of the clinical laboratory?
EM Ransom, CAD Burnham, L Jones, CS Kraft, LC McDonald, ...
Clinical chemistry 66 (4), 512-517, 2020
52020
Routine use of anaerobic blood culture bottles for specimens collected from adults and children enhances microorganism recovery and improves time to positivity
EM Ransom, CAD Burnham
Journal of clinical microbiology 60 (9), e00500-22, 2022
32022
Multiplatform assessment of saliva for SARS-CoV-2 molecular detection in symptomatic healthcare personnel and patients presenting to the emergency department
RF Potter, EM Ransom, MA Wallace, C Johnson, JH Kwon, HM Babcock, ...
The journal of applied laboratory medicine 7 (3), 727-736, 2022
22022
The Next-Generation of Neisseria gonorrhoeae Antimicrobial Resistance Testing
RF Potter, EM Ransom, CAD Burnham
Clinical chemistry 67 (4), 573-575, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20